Related Experiment Video
Updated: Jul 2, 2026

Mechanical Control of Relaxation Using Intact Cardiac Trabeculae
Published on: February 17, 2023
Choosing a skeletal muscle relaxant.
1St. John's University College of Pharmacy and Allied Health Professions, Jamaica, New York 11439, USA. sees@stjohns.edu
Skeletal muscle relaxants offer short-term relief for acute low back pain when other options fail. However, evidence is limited, and choices should prioritize side effects and patient factors over proven superiority.
Area of Science:
- Pharmacology
- Musculoskeletal Medicine
- Evidence-Based Practice
Background:
- Skeletal muscle relaxants are frequently prescribed for musculoskeletal conditions.
- Existing evidence for their efficacy often stems from methodologically weak studies.
- These agents have not demonstrated superiority over acetaminophen or NSAIDs for low back pain.
Purpose of the Study:
- To evaluate the effectiveness and comparative data of skeletal muscle relaxants.
- To inform clinical decision-making regarding the use of these medications.
Main Methods:
- Systematic reviews and meta-analyses were examined.
- Comparison studies of different skeletal muscle relaxants were assessed.
- Effectiveness and adverse effect profiles were analyzed.
Main Results:
- Systematic reviews support short-term use for acute low back pain if other analgesics are ineffective or not tolerated.
- No single skeletal muscle relaxant has proven superior to others in comparative studies.
- Cyclobenzaprine is well-studied; tizanidine and cyclobenzaprine offer sedation benefits, while methocarbamol and metaxalone are less sedating but have limited evidence.
- Common adverse effects include dizziness and drowsiness.
Conclusions:
- Skeletal muscle relaxants can be useful for acute low back pain but lack strong evidence of superiority.
- Selection should be individualized based on side effect profiles, patient preference, and drug interactions.
- Clear communication of potential adverse effects to patients is crucial.
More Related Videos
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...

